Clinical Scorecard: Improving Management of Bone and Joint Infections via Educational Initiatives
At a Glance
Category
Detail
Condition
Bone and joint infections including periprosthetic joint infection, diabetic foot infections, vertebral osteomyelitis, spinal implant infections, and other musculoskeletal infections
Key Mechanisms
Complex interplay of microbiology, musculoskeletal anatomy, biofilm formation, surgical intervention, and orthopedic hardware involvement
Target Population
Infectious diseases clinicians managing musculoskeletal infections, orthopedic patients with implants or comorbidities such as diabetes and immunosuppression
Rising incidence of bone and joint infections driven by aging population, increased orthopedic procedures, comorbidities, and antibiotic resistance
High morbidity, mortality, and financial costs associated with infections such as periprosthetic joint infections and diabetic foot infections
Educational gaps exist in infectious diseases training regarding musculoskeletal infections, necessitating specialized resources and multidisciplinary management
Guideline-Based Recommendations
Diagnosis
Utilize multidisciplinary expertise including infectious diseases and orthopedic specialists for accurate diagnosis
Prioritize high-quality evidence from randomized controlled trials, meta-analyses, and large observational studies for clinical decision-making
Management
Adopt multidisciplinary management approaches involving MSK-ID-trained physicians and orthopedic surgeons
Consider surgical intervention and tailored antimicrobial therapy based on infection type and implant involvement
Recognize the limited success of some treatments such as debridement and implant retention in spinal implant infections
Monitoring & Follow-up
Ongoing evaluation of treatment success and complications, especially in high-risk infections like diabetic foot infections and periprosthetic joint infections
Utilize educational tools and updated literature to inform monitoring strategies
Risks
High 5-year mortality rates associated with periprosthetic joint infections and diabetic foot infections requiring amputation
Financial burden exceeding $100,000 per patient for orthopedic surgical site infections
Challenges posed by antibiotic-resistant organisms and biofilm-associated infections
Patient & Prescribing Data
Patients with musculoskeletal infections including those with orthopedic implants, diabetes-related foot infections, and spinal implant infections
Treatment success varies; for example, spinal implant infections have a 71%-73% success rate with debridement and implant retention; suppressive antibiotic therapy role remains unclear
Clinical Best Practices
Implement specialized educational initiatives such as online libraries and podcasts to improve clinician preparedness
Prioritize high-level evidence and contemporary research (post-2013) for clinical guidance
Encourage multidisciplinary collaboration between infectious diseases specialists and orthopedic surgeons
Utilize curated, peer-reviewed literature repositories to navigate conflicting and variable-quality studies
Incorporate user feedback mechanisms to continuously update educational resources
